Home - Gastroenterology Advisor
WEBCyclic Vomiting Syndrome: AGA Issues Practice Update on Diagnosis and Management. By Allison Nguyen, PharmD. The American Gastroenterological Association has outlined updated guidance on the management of cyclic vomiting syndrome.
Clinician Insights on How to Manage Semaglutide-Induced …
WEBSep 8, 2023 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...
What We Know About Semaglutide Adverse Events and …
WEBSep 1, 2023 · What Are Other Causes of Gastroparesis? Diabetes is the most common underlying cause of gastroparesis and can damage the vagus nerve, leading to impaired muscular function in the stomach and small intestine. 3 Studies show that the 10-year cumulative incidence of diabetic gastroparesis is estimated to be 5.2% among patients with type 1 diabetes and 1% in patients with type 2 diabetes. 4
Endoscopic Remission in UC Best Achieved With Upadacitinib
WEB1 day ago · The interventions that were best at maintaining endoscopic remission were upadacitinib (SUCRA, 87.1%) and etrasimod upadacitinib (SUCRA, 77.7%). For the outcome of histological remission, all biologic and small molecule therapies were more efficacious than placebo, except for adalimumab and …
Liraglutide Efficacious, Safe for Children Aged 6 to <12 Years
WEB1 day ago · HealthDay News — Liraglutide plus lifestyle intervention is efficacious for children aged 6 to <12 years with obesity, according to a study published online Sept. 10 in the New England Journal of Medicine to coincide with the European Association for the Study of Diabetes Congress, held Sept. 9 to 13 in Madrid. Claudia K. Fox, M.D., from the ...
Intestinal Ultrasound for IBD: Clinical Practice Update From the AGA
WEBAug 2, 2024 · The American Gastroenterological Association (AGA) released a clinical practice update in Clinical Gastroenterology and Hepatology about the role of intestinal ultrasound (IUS) in the management of inflammatory bowel diseases (IBDs).. The primary objectives in IBD management are to reverse endoscopically evident inflammation, maintain long-term remission, and to avoid complications.
2021 American College of Gastroenterology Guidelines: Upper ...
WEBJun 2, 2021 · The American College of Gastroenterology (ACG) released clinical guidelines on upper gastrointestinal (GI) and ulcer bleeding using an evidence-based approach, which was recently published in The American Journal of Gastroenterology.. The researchers used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology to develop 16 clinical recommendations for the ...
Short-Acting GLP-1 RAs May Increase GERD, Barrett Esophagus …
WEBMay 12, 2023 · Short-acting glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) are associated with increased risk for developing gastroesophageal reflux disease (GERD) and its associated complications, according to study results presented at Digestive Disease Week (DDW), held from May 6 to 9, 2023 in Chicago, Illinois, and virtually.
Dupilumab Safely Improves EoE Symptoms, Regardless of Prior ...
WEBOct 25, 2022 · Dupilumab safely and efficaciously improved clinical, histologic, endoscopic, and symptomatic measures of eosinophilic esophagitis (EoE), regardless of previous treatment with swallowed topical corticosteroids (STCs), according to study results presented at the American College of Gastroenterology (ACG) 2022 Annual Meeting, held from October 21 to 26, 2022, in Charlotte, North Carolina, and ...
Systemic Glucocorticoid Therapy Linked to Elevated Risk for New …
WEB4 days ago · Exposure to systemic glucocorticoids more than doubles the risk for new-onset diabetes among hospitalized patients, according to the results of a study presented at the 60th Annual Meeting of the European Association for the Study of Diabetes, held from September 9 to 13, 2024 in Madrid, Spain.
Skip to content